2026-07-28T11:57:13-04:00 2025-12-31 141604297 RBT CPAS LLP 11 RACQUET RD NEWBURGH NY 12550 990 2025-01-01 133865754 THE NEW YORK GLAUCOMA RESEARCH INSTITUTE NEWY 9173597390 455 EAST 57TH STREET 14D NEW YORK NY 10022 ROBERT RITCH MD PRES. AND DIRECTOR 9173597390 2026-07-27 true DALE M HLAVACEK CPA P01312818 8455679000 2026-07-27 2025 2025-03-06 01:10:19Z ROBERT RITCH MD 455 EAST 57TH STREET 14D NEW YORK NY 10022 307738 false X WWW.GLAUCOMA.NET/NYGRI X 1995 NY TO PROMOTE RESEARCH INTO THE BASIC CAUSES OF GLAUCOMA, DEVELOP NEW TREATMENT MODALITIES FOR GLAUCOMA, AND DEVELOP PUBLIC EDUCATION INTO THE TREATMENT OF GLAUCOMA. 2 2 0 0 12760 57025 0 72706 60288 0 85466 117313 0 0 0 0 7101 13450 85892 13450 85892 72016 31421 1236452 1441346 1036 17438 1235416 1423908 TO PROMOTE RESEARCH INTO THE BASIC CAUSES OF GLAUCOMA, DEVELOP NEW TREATMENT MODALITIES FOR GLAUCOMA, AND DEVELOP PUBLIC EDUCATION INTO THE TREATMENT OF GLAUCOMA. false false 46751 CONTINUED SCIENTIFIC RESEARCH INTO CAUSES AND TREATMENT OF GLAUCOMA AND THE ISSUANCE OF RELATED INFORMATION PUBLICATIONS. 46751 true true false false false false false false false false true false false false true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false 5 0 false 0 false false false false false false false false X 2 2 false false false false false false false true true false false true true true true true true false false false NY X RYOICHI SAITO 9173597390 455 EAST 57TH STREET 14D NEW YORK NY 10022 X MARSHALL J GLUCK SECRETARY 1.00 X X 0 0 0 ROBERT RITCH MD PRES. AND DI 10.00 X X 0 0 0 RYOICHI SAITO TREASURER 1.00 X 0 0 0 false false false 57025 57025 58462 58462 192251 190425 1826 1826 1826 117313 60288 X 37824 18912 18912 9097 4030 1866 3201 23439 11720 11262 457 13773 10330 3443 559 559 1200 1200 85892 46751 32040 7101 88312 96838 37620 37620 1148140 1344508 1236452 1441346 1036 17438 1036 17438 X 1235416 1423908 1235416 1423908 1236452 1441346 31421 157071 X false false X 3305 90 14050 12760 57025 87230 3305 90 14050 12760 57025 87230 56920 30310 25887 28292 54401 61600 58462 228642 11106 11106 326978 2565 0.09270 0.33360 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED CREDIT CARD PAYABLE 17438 17438 FORM 990, PAGE 6, PART VI, LINE 11B FORM 990 PROVIDED TO BOARD FOR REVIEW BEFORE PROCESSING. FORM 990, PAGE 6, PART VI, LINE 12C ANY DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS HAS A DUTY TO DISCLOSE ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST. AFTER DISCLOSURE, THE INTERESTED PERSON SHALL LEAVE THE BOARD MEETING WHILE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. PROCEDURES FOR ADDRESSING THE CONFLICT INCLUDE- 1. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE BOARD MEETING, BUT SHALL LEAVE THE MEETING DURING DISCUSSION AND VOTE ON THE TRANSACTION OR ARRANGEMENT 2. A DISINTERESTED PERSON OR COMMITTEE WILL INVESTIGATE ALTERNATIVE TRANSACTIONS OR ARRANGEMENTS 3. THE BOARD SHALL DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT 4. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE, THE BOARD SHALL DETERMINE BY MAJORITY VOTE IF THE TRANSACTION OR ARRANGEMENT IS IN THE ORGANIZATION'S BEST INTEREST. IF THE BOARD HAS REASONABLE CAUSE TO BELIEVE A MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, THE MEMBER WILL BE GIVEN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE AND THE BOARD WILL INVESTIGATE AND TAKE APPROPRIATE CORRECTIVE ACTION. FORM 990, PAGE 6, PART VI, LINE 19 NO DOCUMENTS AVAILABLE TO THE PUBLIC FORM 990, PART IX, LINE 11G PROFESSIONAL FEES 18,912 18,912 0